Suppr超能文献

玻璃体内注射曲安奈德治疗复杂性增殖性糖尿病视网膜病变和增殖性玻璃体视网膜病变。

Intravitreal triamcinolone for treatment of complicated proliferative diabetic retinopathy and proliferative vitreoretinopathy.

作者信息

Munir Wuqaas M, Pulido Jose S, Sharma Mithlesh C, Buerk Bruce M

机构信息

Department of Opthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA.

出版信息

Can J Ophthalmol. 2005 Oct;40(5):598-604. doi: 10.1016/S0008-4182(05)80052-3.

Abstract

BACKGROUND

We present a retrospective evaluation of the clinical outcome and complications associated with intravitreal injection of unaltered triamcinolone acetonide in conjunction with pars plana vitrectomy and silicone oil injection for the treatment of complicated proliferative diabetic retinopathy with tractional retinal detachment and severe proliferative vitreoretinopathy.

METHODS

Thirteen eyes of 12 consecutive patients were identified from a computerized patient database. All eyes were operated on by the same surgeon and received 4 mg of unaltered, commercially available triamcinolone acetonide intravitreally, before silicone oil injection. The patients were followed for a mean of 4.7 months (range 1-15 months), and demographic as well as pertinent preoperative and postoperative clinical information was gathered.

RESULTS

At the last follow-up visit, vision had improved in 4 eyes, remained stable in 5 eyes, and worsened in 4 eyes. The retina was attached at the end of follow-up in 10 of the 13 eyes. Eight of the 13 eyes did not show any clinical signs of re-roliferation or redetachment during the course of follow-up. The mean intra-ocular pressure did not increase (preoperative value was 10.8+/- 6.22 mm Hg with a range of 0-22 mm Hg; at last follow-up, mean pressure was 9.6 +/-3.86 mm Hg with a cumulative postoperative range of 0-26 mm Hg). Steroid crystals were visible at 1 month postoperatively in 3 eyes and did not hinder fundus examination significantly.

INTERPRETATION

The intravitreal injection of low-dose, unaltered triamcinolone acetonide in the setting of pars plana vitrectomy and silicone oil injection for the treatment of proliferative vitreoretinopathy and complicated proliferative diabetic retinopathy appears to be well tolerated. Further controlled study is needed to clearly define the potential beneficial effects of intravitreal steroids in these 2 disease processes.

摘要

背景

我们对玻璃体内注射未改变的曲安奈德联合玻璃体切割术及硅油注射治疗伴有牵拉性视网膜脱离和严重增生性玻璃体视网膜病变的复杂性增生性糖尿病视网膜病变的临床结局及并发症进行了回顾性评估。

方法

从计算机化患者数据库中识别出连续12例患者的13只眼。所有眼睛均由同一位外科医生进行手术,并在注射硅油前玻璃体内注射4mg未改变的市售曲安奈德。对患者进行了平均4.7个月(范围1 - 15个月)的随访,并收集了人口统计学资料以及相关的术前和术后临床信息。

结果

在最后一次随访时,4只眼视力改善,5只眼视力稳定,4只眼视力恶化。13只眼中有10只在随访结束时视网膜复位。13只眼中有8只在随访过程中未出现任何再增生或视网膜再脱离的临床体征。平均眼压未升高(术前值为10.8±6.22mmHg,范围为0 - 22mmHg;在最后一次随访时,平均眼压为9.6±3.86mmHg,术后累积范围为0 - 26mmHg)。术后1个月时,3只眼中可见类固醇结晶,且对眼底检查无明显妨碍。

解读

在玻璃体切割术及硅油注射治疗增生性玻璃体视网膜病变和复杂性增生性糖尿病视网膜病变的情况下,玻璃体内注射低剂量、未改变的曲安奈德似乎耐受性良好。需要进一步的对照研究来明确玻璃体内注射类固醇在这两种疾病过程中的潜在有益作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验